Press releases

05 novembre 2018

Press release November 2018

Looking for Partnership(s) to make our solution a reality, in a very ambitious schedule !

May 28 2019

Press release May 2019

AmyPore has just signed the very selective H2020 program of the European Commission for the development of its therapeutic peptide AmyP53.